Optimal timing of heart transplantation in patients with an implantable left ventricular assist device

Suk Ho Sohn1, Yoonjin Kang1, Ho Young Hwang1

  • 1Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

Insights

Left ventricular assist devices (LVADs) offer benefits for heart failure patients awaiting heart transplantation (HTPL). However, LVADs have limitations, and optimal timing for HTPL post-LVAD requires further research.

Area of Science:

  • Cardiovascular Surgery
  • Heart Failure Management
  • Mechanical Circulatory Support

Background:

  • Heart transplantation (HTPL) is the gold standard for end-stage heart failure.
  • Increasing reliance on left ventricular assist devices (LVADs) as a bridge to HTPL due to donor scarcity.
  • Over half of current HTPL recipients utilize durable LVADs.

Purpose of the Study:

  • To review the benefits and limitations of LVADs used as a bridge to HTPL.
  • To evaluate current literature on the optimal timing for HTPL after LVAD implantation.

Main Methods:

  • Narrative review of existing literature.
  • Analysis of benefits and shortcomings of LVADs.
  • Examination of studies concerning HTPL timing post-LVAD.

Main Results:

  • LVADs provide significant advantages for patients awaiting HTPL.
  • Limitations of LVADs include loss of pulsatility, thromboembolism, bleeding, and infection.
  • Limited studies exist on optimal HTPL timing with third-generation LVADs.

Conclusions:

  • LVADs are crucial in managing heart failure patients awaiting transplantation.
  • Further research is necessary to establish definitive guidelines for HTPL timing after LVAD implantation, especially with advanced devices.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
17
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11